(Total Views: 581)
Posted On: 05/25/2021 3:56:03 PM
Post# of 155729
Sounds like all the critical trial dosing will be 700mg given via IV (no sub-q).
That should work......and other than the severe (moderate III) trial reducing to 350mg after first dose, I like these protocols. Like someone else referenced, I would like to see a 3rd arm where 700mg was given for all doses verses a reduction to 350mg.
Quote:
Leronlimab or placebo will be administered by 30-minute intravenous (IV) infusion weekly over a 4-week treatment period. No treatments will be administered post-discharge.
That should work......and other than the severe (moderate III) trial reducing to 350mg after first dose, I like these protocols. Like someone else referenced, I would like to see a 3rd arm where 700mg was given for all doses verses a reduction to 350mg.
(10)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
